Home › Cell Therapeutics soars 24 percent after drug deal with Baxter
 

Keywords :   


Cell Therapeutics soars 24 percent after drug deal with Baxter

2013-11-16 09:10:33| Biotech - Topix.net

The two companies agreed to jointly develop and market the drug, which is being tested in a late-stage trial, in a deal that could fetch Cell Therapeutics' up to $362 million, including an equity investment by Baxter.

Tags: with cell deal drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.07Atlantic Tropical Weather Outlook
06.07Tropical Storm Beryl Public Advisory Number 30A
06.07Summary for Tropical Storm Beryl (AT2/AL022024)
06.07Eastern North Pacific Tropical Weather Outlook
06.07Tropical Storm Beryl Potential Storm Surge Flooding Map
06.07Tropical Storm Beryl Probabilistic Storm Surge Graphics
06.07Tropical Storm Beryl Forecast Discussion Number 30
06.07Tropical Storm Beryl Graphics
More »